Transcranial Magnetic Stimulation in Treatment of Attention Deficit/Hyperactivity Disorders
- Conditions
- Attention Deficit/Hyperactivity Disorder
- Interventions
- Device: Transcranial Magnetic Stimulation (Magstim, Rapid)Other: Placebo Treatment
- Registration Number
- NCT01618110
- Lead Sponsor
- Shalvata Mental Health Center
- Brief Summary
* ADHD is one of the most common psychiatric disorders.
* While most of the attention is directed towards youth, 60% continue to suffer symptoms into adult life.
* Current treatment is effective, but 30% suffer side effects that lowers QOL, and 20% are non-responders.
* Known mechanism of pathophysiology includes hypoactive dopaminergic system, especially at right PFC.
* It is this study hypothesis that by stimulating the right PFC by TMS, it will be possible to alleviate ADHD symptoms.
* A 10 sessions of treatment will by applied on a randomly allocated group of patients, diagnosed with ADHD, in a 2:1 ratio: The first group will receive an actual TMS treatment, and the second group will receive a sham treatment.
* Improvement of objective and subjective ADHD scale will be examined.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
- Age 18-50
- Established diagnosis of ADHD
- No C/I for TMS
- Has signed an informed consent form
- Major Psychiatric disorders (Psychotic or Affective)
- Active use of drugs (4 weeks prior to participation)
- Neurologic disorder such as Epilepsy.
- No use of stimulants during the previous 7 days
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Treatment Group Transcranial Magnetic Stimulation (Magstim, Rapid) - Sham group Placebo Treatment Sham TMS coil (same noise, minimal magnetic field)
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Shalvata MHC
🇮🇱Hod Hasharon, Israel